From survodutide titration to oral PCSK9 adherence and HF care models, AHA 2026 experts pointed to pharmacists as key to putting new data into practice.
|Videos|May 22, 2018
How Pharmacists Can Be Political Advocates for the Profession
In this clip, Scott Douglas, a senior policy director at Crowell & Moring, discusses what pharmacists can do to advocate for the profession in the political arena.
Advertisement
In this clip, Scott Douglas, a senior policy director at Crowell & Moring, discusses what pharmacists can do to advocate for the profession in the political arena.
This video was filmed at the 2018 American Society of Consultant Pharmacists Forum in Arlington, Virginia.
Advertisement
Related to this article
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Structured Blood Glucose Testing: Why Timing Matters
2
Earlier PRRT in Neuroendocrine Tumors Puts Pharmacists at the Center of Coordination
3
From Recognition to Prior Authorization: ATTR-CM Diagnosis Gaps
4
Glucose Monitoring: Timing Makes Every Reading Count
5